Azasite, Azithromycin, Zithromax, Zmax (azithromycin) is a small molecule pharmaceutical. Azithromycin was first approved as Azasite on 1991-11-01. It is used to treat bacterial infections, chlamydia infections, haemophilus infections, infectious skin diseases, and mycoplasma pneumonia amongst others in the USA. It is known to target motilin receptor. Azithromycin's patent is valid until 2024-02-14 (FDA).
|Trade Name||Azasite, Azithromycin, Zithromax, Zmax|
|Indication||bacterial infections, chlamydia infections, haemophilus infections, infectious skin diseases, mycoplasma pneumonia, neisseriaceae infections, nontuberculous mycobacterium infections, otitis media, protozoan infections, staphylococcal infections, streptococcal infections, tonsillitis, urethritis|
|Drug Class||Antibiotics (Streptomyces strains)|